People’s Bank of China Injects 165 Billion Yuan to Stabilize Financial Markets

The People’s Bank of China (PBOC) has recently injected 165 billion yuan into the financial system through 7-day reverse repurchase agreements, keeping its fixed rate at 1.40%. This action is part of ongoing liquidity operations aimed at maintaining smooth functioning in China’s interbank market, rather than initiating a new round of monetary easing.

Understanding Reverse Repos

A reverse repo is a short-term collateralized loan where the PBOC buys securities from primary dealers, typically large commercial banks, with an agreement to sell them back in seven days. This process allows cash to flow into the banking system temporarily. The 1.40% rate on these operations has remained unchanged throughout 2026, serving as the PBOC’s de facto benchmark policy rate.

Unlike the Federal Reserve, which signals through rate changes, the PBOC adjusts liquidity volumes while keeping rates stable. On certain trading days, gross reverse repo transactions have reached as high as 7,620 billion yuan, making the 165 billion yuan net injection appear modest in comparison, yet it is the net figure that alters the liquidity available to banks.

Expanding Tools for Liquidity Management

In addition to the 7-day reverse repo, the PBOC has introduced an overnight reverse repo facility priced initially at 1.25%. This tool allows for more precise liquidity injections, particularly during seasonal pressures that can spike short-term borrowing costs. Together, these facilities create a corridor system, with the 7-day rate setting broader policy signals and the overnight rate providing a floor for very short-term lending.